PAPER
Synthesis of (Z)-2-(1-Iodo-1-organyl)methylenecycloalkanones
2461
1H NMR (400 MHz, CDCl3): d = 7.60–7.56 (m, 2 H), 7.50–7.46 (m,
1 H), 7.42–7.38 (m, 2 H), 3.22 (t, 2 H, J = 5.6 Hz), 2.72 (t, 2 H,
J = 6.4 Hz), 1.95–1.84 (m, 4 H).
13C NMR (100 MHz, CDCl3): d = 187.5, 133.5, 131.2, 129.1, 120.3,
91.5, 88.1, 44.6, 32.9, 25.4, 6.3.
4f
IR (neat): 2929, 1698, 1601, 1508, 1398, 1212, 1177, 818 cm–1.
1H NMR (400 MHz, CDCl3): d = 7.07 (d, 2 H, J = 8.0 Hz), 6.84 (d,
2 H, J = 8.4 Hz), 4.74 (s, 2 H), 3.22–3.18 (m, 2 H), 2.81–2.77 (m, 2
H), 2.31 (s, 3 H), 1.89–1.71 (m, 6 H).
MS (EI): m/z (%) = 313 [(M + 1)+, 26.0], 231 (15.8), 185 (49.9), 129
(100).
13C NMR (100 MHz, CDCl3): d = 200.2, 138.3, 131.4, 130.1, 115.4,
96.2, 95.2, 36.3, 33.5, 29.3, 27.4, 23.1, 20.6, 6.8.
Anal. Calcd for C13H13IO: C, 50.02; H, 4.20. Found: C, 50.10; H,
4.12.
MS (EI): m/z (%) = 370 (M+, 3.8), 254 (28.1), 127 (15.2), 91 (100),
55 (19.2), 41 (11.1).
Anal. Calcd for C16H19IO2: C, 51.91; H, 5.17. Found: C, 52.01; H,
5.23.
4b
IR (neat): 2957, 2929, 2870, 1703, 1672, 1401, 1207, 1102 cm–1.
1H NMR (400 MHz, CDCl3): d = 3.24 (t, 2 H, J = 6.8 Hz), 2.84–
2.80 (m, 2 H), 2.71–2.67 (m, 2 H), 1.96–1.91 (m, 2 H), 1.88–1.83
(m, 2 H), 1.81–1.79 (m, 2 H), 1.52–1.45 (m, 2 H), 1.00–0.95 (m, 3
H).
13C NMR (100 MHz, CDCl3): d = 201.1, 100.9, 97.3, 47.8, 37.9,
32.1, 30.6, 24.7, 21.1, 14.3, 6.3.
4h
IR (neat): 2931, 2858, 1703, 909, 732 cm–1.
1H NMR (400 MHz, CDCl3): d = 3.20 (t, 2 H, J = 6.8 Hz), 2.78 (t,
2 H, J = 6.8 Hz), 2.68 (t, 2 H, J = 7.6 Hz), 1.89–1.81 (m, 2 H), 1.74–
1.67 (m, 2 H), 1.61–1.53 (m, 2 H), 1.48–1.36 (m, 6 H), 0.96 (m, 3
H).
MS (EI): m/z (%) = 293 [(M + 1)+, 34.8], 292 (M+, 21.1), 271 (21.4),
211 (23.9), 183 (31.7), 65 (63.9), 109 (100), 41 (71.0).
13C NMR (100 MHz, CDCl3): d = 201.2, 100.4, 93.4, 47.5, 38.8,
33.2, 30.2, 27.9, 23.1, 21.5, 14.0, 7.1.
Anal. Calcd for C11H17IO: C, 45.22; H, 5.86. Found: C, 45.29; H,
5.92.
MS (EI): m/z (%) = 321 [(M + 1)+, 11.2], 320 (M+, 4.8), 239 (16.7),
193 (10.7), 109 (61.1), 81 (38.3), 55 (59.4), 41 (100).
Anal. Calcd for C13H21IO: C, 48.76; H, 6.61. Found: C, 48.69; H,
6.68.
4c
IR (neat): 2922, 1704, 1611, 1509, 1398, 1212, 1175, 817 cm–1.
1H NMR (400 MHz, CDCl3): d = 7.11 (d, 2 H, J = 8.4 Hz), 6.83 (d,
2 H, J = 8.8 Hz), 4.74 (s, 2 H), 3.21 (t, 2 H, J = 6.8 Hz), 2.81 (t, 2
H, J = 6.4 Hz), 2.30 (s, 3 H), 1.93–1.90 (m, 2 H), 1.83–1.80 (m, 2
H).
13C NMR (100 MHz, CDCl3): d = 200.2, 155.3, 131.4, 130.1, 115.4,
96.2, 95.1, 37.3, 32.5, 29.3, 24.1, 20.5, 5.8.
4i
IR (neat): 2930, 2858, 1704, 1611, 1509, 1213, 1176, 908, 733 cm–1.
1H NMR (400 MHz, CDCl3): d = 7.11 (d, 2 H, J = 8.0 Hz), 6.83 (d,
2 H, J = 8.0 Hz), 4.74 (s, 2 H), 3.19 (t, 2 H, J = 6.8 Hz), 2.78 (t, 2
H, J = 7.2 Hz), 2.30 (s, 3 H), 1.87–1.80 (m, 2 H), 1.73–1.69 (m, 2
H), 1.46–1.39 (m, 4 H).
MS (EI): m/z (%) = 356 (M+, 30.9), 244 (12.9), 187 (30.7), 135
(54.1), 107 (88.7), 77 (100), 55 (93.9), 41 (54.1).
13C NMR (100 MHz, CDCl3): d = 200.7, 140.3, 131.3, 130.1, 115.3,
96.9, 96.6, 36.5, 33.2, 31.1, 30.1, 27.8, 23.0, 20.5, 6.9.
Anal. Calcd for C15H17IO2: C, 50.58; H, 4.81. Found: C, 50.64; H,
4.88.
MS (EI): m/z (%) = 384 (M+, 26.7), 239 (9.4), 187 (18.4), 173
(33.5), 159 (21.8), 145 (44.3), 108 (100), 77 (68.8), 41 (73.3).
Anal. Calcd for C17H21IO2: C, 53.14; H, 5.51. Found: C, 53.19; H,
5.58.
4d
IR (neat): 3060, 2931, 2855, 1663, 1597, 1446, 1265, 1220, 700
cm–1.
4j
1H NMR (400 MHz, CDCl3): d = 8.00–7.96 (m, 2 H), 7.62–7.56 (m,
1 H), 7.54–7.47 (m, 2 H), 2.57 (t, 2 H, J = 6.0 Hz), 2.24 (t, 2 H,
J = 6.0 Hz), 1.76–1.72 (m, 2 H), 1.61–1.44 (m, 4 H).
13C NMR (100 MHz, CDCl3): d = 193.5, 150.0, 134.4, 134.1, 130.4,
129.1, 88.2, 39.3, 33.6, 27.9, 27.8, 26.2.
IR (neat): 3062, 3029, 2930, 2856, 1703, 1496, 1454, 1396, 1206,
1099, 739, 698 cm–1.
1H NMR (400 MHz, CDCl3): d = 7.49–7.38 (m, 5 H), 4.61 (s, 2 H),
4.38 (s, 2 H), 3.26 (t, 2 H, J = 7.2 Hz), 2.84 (t, 2 H, J = 7.6 Hz), 1.91
(t, 2 H, J = 6.8 Hz), 1.79 (t, 2 H, J = 6.8 Hz), 1.52 (m, 4 H).
MS (EI): m/z (%) = 327 [(M + 1)+, 50.3], 326 (M+, 29.6), 199 (75.9),
157 (22.5), 129 (21.2), 105 (100), 77 (31.1).
13C NMR (100 MHz, CDCl3): d = 200.8, 137.1, 128.5, 128.1, 128.0,
97.7, 95.6, 78.5, 72.1, 38.5, 33.2, 30.2, 27.9, 23.0, 7.1.
Anal. Calcd for C14H15IO: C, 51.55; H, 4.64. Found: C, 51.48; H,
4.70.
MS (EI): m/z (%) = 385 [(M + 1)+, 2.1], 384 (M+, 0.6), 239 (4.1),
181 (6.0), 91 (100), 65 (9.1), 41 (16.6).
Anal. Calcd for C17H21IO2: C, 53.14; H, 5.51. Found: C, 53.08; H,
5.55.
4e
IR (neat): 3029, 2929, 2857, 1703, 1453, 1398, 1105, 738, 698 cm–1.
1H NMR (400 MHz, CDCl3): d = 7.43–7.31 (m, 5 H), 4.55 (s, 2 H),
4.31 (s, 2 H), 3.21 (t, 2 H, J = 6.8 Hz), 2.79 (t, 2 H, J = 6.4 Hz),
1.89–1.86 (m, 2 H), 1.76–1.72 (m, 2 H), 1.51–1.47 (m, 2 H).
13C NMR (100 MHz, CDCl3): d = 200.6, 137.1, 128.5, 128.1, 128.0,
97.7, 95.3, 78.5, 72.1, 38.4, 33.2, 29.9, 22.2, 6.5.
MS (EI): m/z (%) = 370 (M+, 1.0), 254 (24.5), 127 (16.7), 91 (100),
55 (13.8), 41 (16.8).
(Z)-2-(1-Phenyl-1-phenylethynyl)methylenecyclooctanone (5g)
Under N2, a slurry of the 4g (170 mg, 0.5 mmol), phenylacetylene
(61 mg, 0.6 mmol), PdCl2(PPh3)2 (17 mg, 5 mol%), CuI (9.5 mg, 10
mol%), K2CO3 (207 mg, 1.5 mmol) in MeCN (15 mL) was stirred
at 60 °C for 12 h. The reaction mixture was filtered through a short
pad of silica gel to remove precipitated inorganic salts. The silica
gel pad was washed three times with a small amount of EtOAc and
the combined solution was evaporated to dryness under reduced
pressure. The residue was chromatographed on silica gel using n-
hexane–EtOAc (20:1) as eluent to give 144 mg (92%) of 5g.
Anal. Calcd for C16H19IO2: C, 51.91; H, 5.17. Found: C, 51.81; H,
5.20.
Synthesis 2004, No. 15, 2459–2462 © Thieme Stuttgart · New York